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Model peptide for anti-sigma factor domain HHCC
zinc ﬁngers: high reactivity toward 1O2 leads to
domain unfolding†
Valentin Chabert, ‡a Vincent Lebrun,‡a Colette Lebrun, b Jean-Marc Latour a
and Olivier Se´ne`que *a
All organisms have to copewith the deleterious eﬀects of reactive oxygen species. Some of them are able to
mount a transcriptional response to various oxidative stresses, which involves sensor proteins capable of
assessing the redox status of the cell or to detect reactive oxygen species. In this article, we describe the
design, synthesis and characterization of Zn$LASD(HHCC), a model for the Zn(Cys)2(His)2 zinc ﬁnger site
of ChrR, a sensor protein involved in the bacterial defence against singlet oxygen that belongs to the
family of zinc-binding anti-sigma factors possessing a characteristic H/C–X24/25–H–X3–C–X2–C motif.
The 46-amino acid model peptide LASD(HHCC) was synthetized by solid phase peptide synthesis and its
Zn2+-binding properties were investigated using electronic absorption, circular dichroism and NMR.
LASD(HHCC) forms a 1 : 1 complex with Zn
2+, namely Zn$LASD(HHCC), that adopts a well-deﬁned
conformation with the Zn2+ ion capping a 3-helix core that reproduces almost perfectly the fold of the
ChrR in the vicinity of its zinc site. H2O2 reacts with Zn$LASD(HHCC) to yield a disulﬁde with a second
order rate constant of 0.030 ! 0.002 M"1 s"1. Zn$LASD(HHCC) reacts rapidly with singlet oxygen to yield
sulﬁnates and sulfonates. A lower limit of the chemical reaction rate constant between Zn$LASD(HHCC)
and 1O2 was determined to be 3.9 # 106 M"1 s"1. Therefore, the Zn(Cys)2(His)2 site of Zn$LASD(HHCC)
appears to be at least 5 times more reactive toward these two oxidants than that of a classical bba zinc
ﬁnger. Consequences for the activation mechanism of ChrR are discussed.
Introduction
Organisms living in an aerobic environment have to cope with
the deleterious eﬀects of oxidative stress, which is caused by
a family of molecules produced from dioxygen in the living cell,
the so-called Reactive Oxygen Species (ROS).1 ROS are classied
into two categories according to their production pathways:
Type I for those arising from electron(s) addition to O2 (e.g.:
superoxide anion O2c", hydrogen peroxide H2O2, hypochlorous
acid HOCl, hydroxyl radical HOc.) and Type II for electroni-
cally excited states of dioxygen arising from a physical activation
of the ground (triplet) state (3O2).2–4 The lowest energy excited
state of O2, commonly called singlet oxygen (1O2), is produced
mainly in photosynthetic organisms. These organisms, as well
as others like mammalians, have been shown to elicit a specic
response to 1O2, demonstrating that sensing pathways exist for
this ROS.5–7 One of the best characterized is that of Rhodobacter
sphaeroides. It involves the protein sE, a group IV sigma factor
up-regulating the expression of the response against 1O2
stress.8–11 sE is negatively regulated by its cognate anti-sigma
factor, ChrR. In normal conditions, the anti-sigma factor
sequesters its cognate sigma factor (Fig. 1A). Under 1O2 stress,
the anti-sigma factor undergoes a structural change and
releases its sigma factor, which can then bind RNA polymerase,
up-regulating the expression of specic genes involved in the
response to 1O2 stress. The anti-sigma factor interacts with the
sigma factor mainly via its N-terminal domain, named anti-
sigma factor domain (ASD).10 It is estimated that 33% of the
group IV sigma factors are regulated by an anti-sigma factor
containing an anti-sigma factor domain. Among the predicted
cytoplasmic group IV anti-sigma factors, 92% contain
a conserved zinc binding motif H–X3–C–X2–C, classifying them
in the zinc-binding anti-sigma factor (ZAS) subfamily.8
In 2011, Andreini et al. classied 93% of the 15 763 known
structures of protein zinc sites into a minimum set of structural
motifs.12 The two existing structures of ChrR10 could not enter in
any of the families dened by Andreini, which demonstrates the
singularity of the zinc nger site of their anti-sigma factor
domain. ChrR contains an anti-sigma factor domain featuring
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a HHCC zinc nger site with a H–X24–H–X3–C–X2–C motif
(Fig. 1B). Interestingly, RslA and RsrA, two ChrR homologs
featuring also a zinc nger site – HHCC within a H–X24–H–X3–
C–X2–C motif for RslA13 and CHCC within a C–X25–H–X3–C–X2–
C motif for RsrA14 – are sensitive to oxidative conditions and
trigger a response against oxidative stress.13–16 Noteworthy, the
zinc site of RsrA is described as a redox switch, acting as
a detection module for disulde stress. A similar role was
proposed for the zinc site of RslA to sense oxidative stress.13–16 It
has been proposed that the oxidation of the ZAS protein zinc
nger induces Zn2+ release and unfolding of the anti-sigma
factor domain, leading to dissociation of the ZAS protein from
its cognate sigma factor. However, it was recently demonstrated
that oxidation of zinc-binding cysteine of the ZAS zinc nger is
not always suﬃcient to dissociate the anti-sigma factor–sigma
factor complex.17 Similarly, it has been hypothesized that the
zinc site of ChrR could sense 1O2 via zinc-bound thiol oxidation
inducing dissociation of the anti-sigma factor domain from sE,
which is supported by the demonstration that (i) formation of
the zinc nger site in the N-ter domain anti-sigma factor
domain of ChrR is essential for the ChrR–sE complex forma-
tion, and (ii) the Zn-loaded anti-sigma factor domain alone is
suﬃcient to sequester sE. Additionally, it was also shown that
the C-terminal cupin-like domain of ChrR is required for 1O2
response in vivo,10,11 but there is no data ruling out the
involvement of the zinc nger site – and its oxidation – in these
studies. The full mechanism of activation of ChrR by 1O2
remains to be elucidated.
We have previously shown that small metallopeptides
modelling zinc nger sites are useful tools to gain interesting
insights into the reactivity of zinc ngers toward ROS at the
molecular level (oxidation products, kinetic rates).18–20 In
particular, we have shown that a Zn(Cys)4 zinc nger of the
treble clef family of zinc ngers could be eﬃciently oxidized by
1O2 21 whereas 1O2 oxidation of the Zn(Cys)2(His)2 site of clas-
sical bba zinc ngers is far less eﬃcient.22 This questions the
role of the Zn(Cys)2(His)2 zinc nger in ChrR. To address this
question, we developed a 46-amino acid peptide modelling the
anti-sigma factor domain zinc nger site of ChrR and we
studied its reactivity towards H2O2 and 1O2. We show that its
oxidation leads to Zn2+ release and peptide unfolding.
Remarkably, the cysteines of this uncommon Zn(Cys)2(His)2 site
found in ZAS are rapidly oxidized by 1O2 compared to classical
bba zinc ngers, in agreement with their putative involvement
in 1O2 detection.
Results
Peptide design
To date, two crystal structures of anti-sigma factor domain-
containing proteins displaying a zinc nger site (HHCC type)
have been elucidated: ChrR10 and RslA.13 Anti-sigma factor
domains display four a-helices and among them, three are
involved in the constitution of the zinc nger site, which is
displayed in Fig. 1B. These three helices (H1, H2 and H3) are
held together by the chelation of a Zn2+ ion and by closely
packed hydrophobic side chains within the heart of the 3-helix
core. Helices H2 and H3 (Fig. 1B) form a knuckle bearing the H–
X3–C–X2–C conserved motif, coordinating the Zn2+ ion. The
fourth zinc ligand is a histidine residue located at the N-
terminus resulting in an overall H–X24–H–X3–C–X2–C Zn2+-
binding motif (Fig. 2). In order to reproduce the reactivity of
a given zinc nger site, it is important to perfectly reproduce the
various features of the site that can inuence its reactivity. This
includes the coordination sphere of the Zn2+ ion, the folding of
the peptide around and the hydrogen bonds that are estab-
lished with the Zn2+-bound sulfurs.18,20,23 It has been shown with
RsrA that the anti-sigma factor domain can adopt diﬀerent folds
depending whether it is bound to its sigma-factor or not.17 Since
our aim is to better understand if the reactivity of ChrR's zinc
site could play a role in the sensing of 1O2, we aim here at
reproducing the fold as complexed with sE. Hydrophobic cores
proximal to the zinc nger site can be important to enhance
Zn2+ aﬃnity to the model peptide and to ensure its proper
folding.24 For these reasons, we decided to include the three
helices in our model.
The design of the model peptides was based on the sequence
and X-ray crystallographic structure of ChrR anti-sigma factor
domain (Fig. 2),10 which was re-engineered as follows. (i) In the
HH motif present at the N-terminus, only the second residue is
involved in Zn2+ coordination as part of the canonical H–X24–H–
X3–C–X2–C motif. In order to avoid scrambling of Zn2+ ligand,
the rst histidine of the HH motif was changed for a lysine. (ii)
Helices H1, H2 and H3 present several hydrophobic side chains
Fig. 1 (A) Crystallographic structure of the ChrR–sE complex (pdb
2Z2S)8 showing the sigma factor sE in orange and the anti-sigma factor
ChrR in blue with anti-sigma factor domain in dark blue and cupin-like
domain in light blue. The zinc ion is shown in magenta. (B) View of the
anti-sigma factor domain zinc ﬁnger site embedded within helices H1,
H2 and H3, showing Zn2+-binding histidines and cysteines of the H–
X24–H–X3–C–X2–C motif.
Fig. 2 Sequence alignment of the N-terminal domain of ChrR (top)
and the model peptides presented in this article, Zn2+-binding amino
acids underlined.
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that point toward the exterior of the structure because they are
involved in the interaction with the sigma factor sE. In order to
favour the correct fold of our model peptide and to ensure
solubility, these hydrophobic amino acids were randomly
changed for polar amino acids (E, Q or K). (iii) As b-branched
amino acids such as threonine or valine may destabilize a-
helices,25 two threonines located in helices H1 and H2, and
pointing toward the exterior of the structure were changed for
lysines. Similarly, glycines in helix H3, which may destabilize
a helical fold, were changed for glutamine and alanines. (iv) The
C-terminus of the peptide was amidated to remove the carbox-
ylate charge that could destabilize the C-terminus of helix H3.26
(v) Non-essential aspartates and arginines were changed for
glutamates and lysines to avoid side reactions during solid
phase peptide synthesis (SPPS) and maximize synthesis yields.
This led to peptide L1, whose sequence is displayed in Fig. 2. As
a rst try to model the anti-sigma factor domain zinc nger, this
46-amino acid peptide was synthetized by SPPS. Unfortunately,
when dissolved in various buﬀers at pH around 7, L1 precipi-
tated when Zn2+ was added. Mapping charged amino acids of
the L1 sequence onto the 3-helix motif of ChrR using Pymol27
revealed that most of the negatively charged glutamate residues
are clustered on one face of the structure whereas positively
charged lysines are clustered on another face. Suspecting that
this could be the reason for precipitation of the Zn2+ complex,
the charged amino acids were re-distributed in the sequence for
random disposition onto the 3-helix surface. This led to peptide
LASD(HHCC) (Fig. 2), which was synthetized by SPPS. Note that
four pseudoproline dipeptides28 were used to avoid aggregation
of the elongating chain during synthesis (see ESI† for details).
Zinc binding and folding properties
The metal binding properties of LASD(HHCC) were investigated
by combination of UV-Vis absorption, circular dichroism (CD)
and NMR. Titrations monitored by UV absorption were used to
determine the stoichiometry of the peptide–metal complexes.
Upon addition of Zn2+ in a buﬀered peptide solution, an
increasing absorption band is observed at ca. 220 nm, which
corresponds to Cys$S"/ Zn2+ ligand-to-metal charge transfer
(LMCT) transitions (Fig. 3A).24 This signal increases linearly up
to one equivalent of zinc and plateaus aerwards (inserts
Fig. 3A). This indicates the formation of a 1 : 1 complex only, i.e.
Zn$LASD(HHCC). The intensity of this band is D3 ¼
6600 M"1 cm"1, which is in agreement with two zinc-bound
cysteinates.20,24,29 To gain further insight into the coordination
sphere of the Zn2+ ion, LASD(HHCC) was titrated with Co2+,
a Zn2+ ion surrogate commonly used to probe its geometry and
coordination sphere. Absorption bands characteristic of Cys$S"
/ Co2+ LMCT (in the range 220–400 nm) and d–d (in the range
500–700 nm) transitions appear upon coordination of Co2+ by
LASD(HHCC) (Fig. 3C). Similarly to the Zn2+ titration, only the
1 : 1 Co$LASD(HHCC) complex is detected. The wavelengths
(576, 627 and 670 nm) and intensity (3 ¼ 620 M"1 cm"1 at
627 nm, i.e. 3 > 300 M"1 cm"1) of the d–d transitions are in
agreement with a tetrahedral Co(Cys)2(His)2 site.20,24,30,31 From
these data, we can reasonably infer the formation of
a tetrahedral 1 : 1 Zn$LASD(HHCC) complex with (Cys)2(His)2
coordination. Thereaer, the folding of the peptide was inves-
tigated by CD (Fig. 3B). The CD spectrum of the metal-free
LASD(HHCC) shows an intense negative signal with minimum
at ca. 200 nm and a shoulder at ca. 222 nm. This corresponds to
a random coil peptide with a small content of helical fold. In
agreement with absorption studies, upon titration of
LASD(HHCC) by Zn2+, evolution of the CD spectrum is observed
up to 1 eq. Zn2+ with a clean isodichroic point at 205 nm,
thereby conrming the formation of a complex with 1 : 1 stoi-
chiometry only. The spectrum of Zn$LASD(HHCC) is character-
istic of a peptide with major helix content, as expected for this
model. In order to determine the Zn2+ binding constant of
LASD(HHCC) at pH 7.0, KZnLASD(HHCC) ¼ [Zn$LASD(HHCC)]/([Zn2+]
[LASD(HHCC)]), CD titrations were performed in competition
with EDTA and TPEN (1 eq.), two high-aﬃnity Zn2+ chelators
(KZnEDTA ¼ 1013.1 M"1 and KZnTPEN ¼ 1014.9 M"1 at pH 7.0). In
the case of EDTA, ca. 95% of Zn2+ is bound to LASD(HHCC) aer
addition of 1.0 eq. Zn2+ vs. peptide (ESI†), indicating that
Fig. 3 UV-Vis absorption and CD characterization of LASD(HHCC) and
LASD(AHCC). (A) Absorption and (B) CD monitoring of Zn
2+ titrations of
LASD(HHCC) (19 mM, left) and LASD(AHCC) (14 mM, right) in phosphate
buﬀer (20 mM, pH 7.0) containing TCEP (500 mM) with inserts showing
the evolution of the absorbance at 220 nm. For absorption, the
spectrum of the metal-free peptide was subtracted from each spec-
trum. (C) Absorption monitoring of Co2+ titrations of LASD(HHCC) (153
mM, left) and LASD(AHCC) (110 mM, right) in phosphate buﬀer (20 mM,
pH 7.0) containing TCEP (500 mM) with inserts showing the evolution
of the absorbance at 690 nm for LASD(HHCC) and 660 and 695 nm for
LASD(AHCC).
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LASD(HHCC) binds Zn2+ tighter than EDTA but also that EDTA is
not suitable for precise determination of the binding
constant.32,33 In the case of TPEN, we noticed a slow precipita-
tion of the Zn2+-free peptide in presence of this chelator, which
precluded any competition experiment. Thus, only a lower
estimate of the binding constant can be drawn from the EDTA
competition, that is KZnLASD(HHCC) $ 10
15.0 M"1.
In order to conrm that the N-terminal histidine, which is
remote from the core H–X3–C–X2–C binding motif in the
sequence, is bound to the Zn2+ ion in our Zn$LASD(HHCC)
model, a peptide variant with the N-terminal histidine replaced
by an alanine, namely LASD(AHCC), was synthesized (Fig. 2 and
ESI†). Upon Zn2+ titration, the formation of a 1 : 1 complex only
is evidenced by both UV-Vis absorption and CD spectroscopies
(Fig. 3A and B). The spectral features are very similar for both
peptides, including LMCT absorption and CD spectra, either in
their Zn-free and Zn-loaded forms. The intensity of the LMCT
band (D3 ¼ 8400 M"1 cm"1) is compatible with two zinc-bound
cysteinates. Noteworthy, the CD spectrum of Zn$LASD(AHCC) is
very similar to that of Zn$LASD(HHCC), indicating a similar helix
content in the Zn-loaded form. Regarding Co2+ binding, anal-
ysis of the UV-Vis Co2+ titration of LASD(AHCC) shows
a completely diﬀerent d–d transition pattern compared to
LASD(HHCC) with a two-step growing phase (the bands at 660
and 695 nm have the same intensity at the beginning of the
titration (<0.5 eq.), then the band at 655 nm becomes the most
intense, Fig. 3C), indicating the formation of both 2 : 1 and 1 : 1
Co/peptide species during the titration, with tetrahedral
geometry as attested by the 3 values above 300 M"1 cm"1 for the
d–d transitions. Additionally, no plateau is observed aer 1.0
eq., indicating a less stable 1 : 1 complex compared to
Co$LASD(HHCC). Finally, the binding aﬃnity of LASD(AHCC) for
Zn2+ was assessed by competition with EDTA monitored by CD.
When a 1 : 1 : 1 LASD(AHCC)/EDTA/Zn2+ mixture is prepared, ca.
25% of Zn2+ is bound to LASD(AHCC) versus 95% for LASD(HHCC)
in the same conditions (ESI†). This corresponds to a value of ca.
1012 for KZnLASD(AHCC), indicating that the replacement of the N-
terminal histidine by an alanine lowers the Zn2+ aﬃnity by at
least 3 orders of magnitude.
Further insights into the structure of Zn$LASD(HHCC) and
Zn$LASD(AHCC) were obtained by 1H NMR. The 1D 1H NMR
spectra of metal-free LASD(HHCC) and LASD(AHCC) in H2O/D2O
9 : 1 display broad peaks with amide NH in the range 7.2–
8.5 ppm indicating that these peptides are mostly random coil,
in agreement with CD. Regarding Zn2+ complexes, the 1H NMR
spectrum of Zn$LASD(HHCC) displays sharp amide NH reso-
nances spread over a wider range from 6.9 to 9.3 ppm (Fig. 4A,
top, and ESI†). Many of them present 3JHN,Ha < 6 Hz indicative of
helical folding (Table S2 and Fig. S4 of ESI†). The 2D NOESY
spectrum shows numerous correlation peaks corresponding to
non-sequential NOEs that are characteristic of helical folding
(Fig. S4 of ESI†). Additionally, several long-range NOEs between
hydrophobic amino acid remote in the sequence indicate the
formation of a hydrophobic core. This suggests the formation of
a Zn2+ complex with a well-dened stable conformation. On the
contrary, the 1H NMR spectrum of Zn$LASD(AHCC) (Fig. 4A,
bottom) shows very broad resonances in the amide NH region
although this complex displays a similar helix content as
Zn$LASD(HHCC) as judged from its CD spectrum. This suggests
a conformational equilibrium for Zn$LASD(AHCC). Indeed, the
coordination of the N-terminal histidine to the Zn2+ ion is not
necessary to fold the three helices, as indicated by CD but it
plays a major role in freezing the conformation of the peptide in
HHCC variant. Finally, the structure of Zn$LASD(HHCC) was
calculated using X-PLOR with 466 H–H distance constraints
(142 intraresidue, 138 sequential and 186 medium- and long-
range) extracted from the NOESY spectrum and 35 f dihedral
constraints derived from 3JHN,Ha values. The superimposition of
the ten lowest energy structures, which is depicted on Fig. 4B
shows that Zn$LASD(HHCC) adopts a well-dened conformation
with three helices (the backbone root mean square deviation
over the ten structures is 0.83 A˚). The zinc nger site caps this
three-helix domain (Fig. 4C). The superimposition of the lowest
energy structure of Zn$LASD(HHCC) with the zinc nger site
taken from the crystallographic structure of ChrR anti-sigma
factor domain (Fig. 4D) shows that the model reproduces
almost perfectly the fold of the native protein, including helices
H1, H2 and H3 as well as the loops between the helices. To
summarize, LASD(HHCC) is able to bind only one Zn2+ ion to
form a tetrahedral Zn(Cys)2(His)2 site that folds the peptide into
a unique 3-helix conformation reproducing almost perfectly
that of ChrR anti-sigma factor domain.
Oxidation of Zn$LASD(HHCC) by H2O2
The reactivity of Zn$LASD(HHCC) toward H2O2 and 1O2 was
investigated in order to assess the propensity of the anti-sigma
factor domain zinc nger site to be oxidized by these two
Fig. 4 (A) 1H NMR spectra (500 MHz, H2O/D2O 9 : 1 pH 6.4, 298 K) of
Zn$LASD(HHCC) (top) and Zn$LASD(AHCC) (bottom). (B) Superimposi-
tion of the 10 lowest energy structures of Zn$LASD(HHCC) calculated
using X-PLOR with NMR-derived distance and dihedral angle
constraints. (C) Lowest energy structure of Zn$LASD(HHCC). (D)
Superimposition of the solution structure of Zn$LASD(HHCC) (green)
and the corresponding sub-domain of the crystallographic structure
of ChrR (blue, pdb 2Z2S).10 The Zn2+ ion is shown in magenta.
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oxidants in comparison with other zinc ngers. The reaction of
Zn$LASD(HHCC) (20 mM) with H2O2 (1 mM) in phosphate buﬀer
(10 mM, pH 7.0) was monitored by CD (Fig. S3C of ESI†). This
reaction is slow and aer 15 h, the CD spectrum resembles that
of zinc-free LASD(HHCC), indicating that the peptide unfolds
upon reaction with H2O2. The product of the reaction was
identied by ESI/MS as a disulde (loss of two mass units). A
similar CD spectrum was obtained by reacting Zn$LASD(HHCC)
with 2.5 eq. HOCl, a more eﬃcient oxidant for zinc-bound thi-
olates known to form disuldes.34 The kinetics of the reaction of
Zn$LASD(HHCC) with H2O2 at 298 K was determined using
previously described procedures,19 monitoring either the loss of
the LMCT absorption in the UV or zinc release by using 4-(2-
pyridylazo)resorcinol (PAR), which forms the Zn(PAR)2 complex
with intense absorption in the visible when Zn2+ is released
from the peptide upon oxidation. The PAR assay is not recom-
mended to follow the oxidation of Zn(Cys)3(His) or Zn(Cys)4
because partially oxidized peptides displaying a reduced
cysteine may retain Zn2+,19 but for this Zn(Cys)2(His)2 zinc nger
peptide, both methods gave the same result. In condition of
excess H2O2, a mono-exponential evolution of the absorption
signal (either LMCT or Zn(PAR)2 band at 220 and 494 nm,
respectively) is observed, indicating an apparent pseudo-rst
order reaction. Varying the concentration of H2O2 revealed
a linear dependence on [H2O2] of the apparent rst-order rate
constant kobs (Fig. S3 of ESI†). Thus, the rate-determining step
of the reaction is second order, rst order in H2O2 and rst
order in Zn$LASD(HHCC), as previously observed for other zinc
ngers.18–20 Indeed, the rate-determining step corresponds to
the nucleophilic attack of H2O2 by the zinc-bound thiolate and
its rate is given by r ¼ k # [H2O2][Zn$LASD(HHCC)] with k ¼
0.030 ! 0.002 M"1 s"1 at 297 K.
Oxidation of Zn$LASD(HHCC) by
1O2
In previous studies,21,22 we have shown that the reaction of
Zn(Cys)4 and Zn(Cys)2(His)2 zinc nger models with 1O2 yields
sulnate species as major products, and disuldes in a lesser
extent. Additionally, in a classical bba Zn(Cys)2(His)2 zinc
nger, Zn2+ coordination inhibits photooxidation of histidines.
Oxidation of Zn$LASD(HHCC) by 1O2 was investigated as previ-
ously described for other Zn(Cys)4 and Zn(Cys)2(His)2 zinc
nger models:21,22 the oxidation products were identied by
combination of HPLC and ESI-MS analyses and the reaction rate
was assessed in competition experiments with a reference
compound. Rose bengal or methylene blue were used as
photosensitizers to produce 1O2 in this study. Zn$LASD(HHCC)
was photooxidized in D2O buﬀered with phosphate or
ammonium acetate. HPLC analyses were performed with acidic
eluent (0.1% TFA) so that Zn2+ is removed from the peptide
during analysis. The HPLC chromatogram of a solution of
Zn$LASD(HHCC) containing the photosensitizer but maintained
in the dark showed a single peak at tR ¼ 20.3 min corresponding
to the reduced peptide LASD(HHCC) (Fig. 5B). Upon irradiation,
a second peak appears at a shorter retention time (tR¼ 18.1min).
Prolongated irradiation shows an increase of the peak at 18.1min
at the expense of the one at 20.3 min. The main product detected
by ESI-MS analysis of the crude corresponds to the addition of
two oxygen atoms to the peptide, suggesting the formation of
sulnates. Other peaks corresponding to the addition of three
and four oxygen atoms are also observed. The two HPLC peaks
were collected, digested with glutamate carboxypeptidase (GluC,
a peptidase that cleaves peptides at carboxylic side of glutamates
or aspartates), and digestion mixtures were analysed by ESI-MS
(Fig. 5A and Table S1†). GluC digestion of LASD(HHCC) can give
four fragments: Ac-KHVSKQLLKAYAE (F1), GTLSE (F2), AYSKK-
VAKHLSKC31E(E) (F3) and C34KAKAQKLKAKAA-NH2 (F4). Diges-
tion of both HPLC fractions gave unaltered N-terminal fragments
F1 and F2, meaning that neither His2 nor Tyr11 are photo-
oxidized. However, diﬀerent patterns were observed for the two
cysteine-containing fragments F3 and F4 (Table S1 of ESI†). For
both HPLC fractions, no mass peak corresponding to the
possible F3–F4 disulde was detected. For the fraction eluting at
20.3 min, fragment F3 is unaltered but fragment F4 was detected
in three distinct chemical forms: unaltered and with increase of
32 and 48 mass units. The product with a 32 mass unit increase
was ascribed to the oxidation of Cys34 into a sulnate by
comparison to previous studies.21,22 This was conrmed by the
loss of 66 mass units corresponding to H2SO2 upon MS/MS
fragmentation. The formation of a sulnate upon photooxida-
tion of metal-bound thiolate has already been reported in many
instances for Pt,35–37Ni,38 Pd,38 Co39–41 and Cd42 complexes thereby
supporting the formation of a sulnate for Zn-bond cysteines in
Zn$LASD(HHCC) but the product with a 48-mass unit increase is
more intriguing. As F4 does not contain any amino acid prone to
oxygen incorporation upon photooxidation other than Cys34 (i.e.
His, Tyr, Trp or Met), this product could only be ascribed to the
formation of a sulfonate on Cys34. This hypothesis is supported
by the formation of glutathione sulfonate in the case of photo-
oxidation of glutathione.43 Nevertheless, the mechanism of the
formation of this product, especially the breaking of the O–O
bond in the putative RS(O)(O)–OO" intermediate remains
Fig. 5 (A) GluC digestion sites (dashed lines) and 1O2 oxidation sites
(arrows) identiﬁed for LASD(HHCC). (B) HPLC chromatograms obtained
before (bottom) and after 1 min (middle) and 5 min (top) irradiation of
a solution of Zn$LASD(HHCC) (60 mM) containing rose bengal (2 mM), in
20 mM Pi (D2O pD 7.0). The species identiﬁed by digestion and ESI-MS
analysis of each collected peak are displayed. (C) CD spectra before
(solid line) and after 10 min irradiation (dotted line) of a solution of
Zn$LASD(HHCC) (30 mM) containing rose bengal (3 mM), in 20 mM Pi
(H2O pH 7.0).
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unclear. Altogether, the fraction eluting at 20.3 min contains the
unoxidized peptide LASD(HHCC) as expected but also LASD(-
HHCCSO2) and LASD(HHCCSO3) oxidation products in which Cys34
was photooxidized into a sulnate and a sulfonate, respectively
(Fig. 5A). For the fraction eluting at 18.1 min, only a 32-mass unit
increase was detected for F3, revealing photooxidation of Cys31
into a sulnate (conrmed by loss of 66 mass units upon MS/MS
fragmentation). Photooxidation of Cys31 rather than Tyr20 or
His27 in F3 was supported by unaltered F1 fragment, which
contains also histidine and tyrosine, and was further demon-
strated by the loss of 66 Da corresponding to H2SO2 uponMS–MS
fragmentation. F4 appears within three diﬀerent forms:
unaltered and with +32 and +48 mass units. This indicates the
presence of Cys34 in reduced, sulnate and sulfonate forms in the
fraction eluting at 18.1 min. Therefore, this fraction contains
three peptides: the primary oxidation product LASD(HHCSO2C) and
the overoxidation products LASD(HHCSO2CSO2) and LASD(HHCSO2-
CSO3) (Fig. 5B). Noteworthy, mass analysis always revealed the
presence of overoxidation products, even at short irradiation
times, indicating that the rate of formation of overoxidation
products is at least comparable to the rate of formation of primary
oxidation products LASD(HHCCSO2) and LASD(HHCSO2C).
Then, the rate of chemical reaction between Zn$LASD(HHCC)
and 1O2 (kr) was assessed by competitive photooxidation with the
peptide EGWGK as a competitor (kr(EGWGK) ¼ (4.6 ! 0.5) # 106
M"1 s"1)21 following a procedure described previously.21,22 The
method consists in comparing the consumption of the zinc
nger peptide and the reference compound by HPLC (ESI). In
such a competitive photooxidation experiment, the ratio of the
rate constants kr1 and kr2 of two compounds C1 and C2 is given by
eqn (1) where [Ci]0 and [Ci]f are the concentrations of compound
Ci before and aer photooxidation, respectively.44,45
kr1
kr2
¼
ln
!
½C1&f
.
½C1&0
"
ln
!
½C2&f
.
½C2&0
" (1)
Since we were not able to separate unreacted LASD(HHCC) and
LASD(HHCCSO2) by HPLC and as overoxidation are rapidly formed,
this method underestimates the consumption of LASD(HHCC)
and yields a sizeable underestimation of kr. Nevertheless, a lower
limit of 3.9 # 106 M"1 s"1 for kr(Zn$LASD(HHCC)) was calculated
from the competition experiments. Finally, CD was used to assess
the consequences of 1O2 oxidation of Zn$LASD(HHCC) on the
peptide fold. As shown in Fig. 5C, photooxidation causes
dramatic loss of helical structure, attesting of peptide unfolding.
Discussion
Design and characterization of the anti-sigma factor domain
zinc nger model
For several years, we have been developing peptidic zinc nger
models of small size in order to study the reactivity of zinc nger
sites toward reactive oxygen species such as H2O2,18–20 HOCl34 or
1O2 21,22 at the molecular level. Our approach involves the use of
cyclic and branched peptides, named CPLT (Cyclic Peptides
with Linear Tail),29 to create shortcuts in native zinc nger
sequences. This aﬀords models that reproduce almost perfectly
the fold of native zinc nger domains around the Zn2+ ion with
a minimal set of amino acids. The small size of these models
allowed us to characterize oxidation products and to provide
reliable kinetic data to describe the reactivity of zinc ngers. The
CPLT design is well suited to zinc nger sites harbouring a CXXC
motif in a b-hairpin loop. However, the elaboration of a CPLT
model was not possible for the anti-sigma factor domain due to
its 3-helix core that supports the four Zn2+-binding amino acids.
Therefore, we decided to keep this core but to reduce the size of
the anti-sigma factor domain sequence as much as possible
without altering its fold around Zn2+. Re-engineering of the
amino acid sequence allowed us to get a soluble 46-amino acid
protein that folds upon Zn2+ binding and adopts the same
conformation as that found in the sigma factor/anti-sigma factor
complex. The design strategy used to elaborate this model
revealed some important features: (i) it is necessary to avoid
clustering of negatively or positively charged amino acids on the
surface to provide suﬃcient solubility to the model, (ii) once the
Zn2+ ion coordinated to the H–X3–C–X2–Cmotif, the constitution
of a hydrophobic core within the heart of the 3-helix structure is
most probably the driving force for the protein to get the proper
folding; and (iii) the N-terminal histidine is absolutely required
for conformational stability, providing at least 4 kcal mol"1
stabilization to the system as shown by the comparison between
Zn$LASD(HHCC) and Zn$LASD(AHCC).
H2O2 and
1O2 oxidation
In previous studies on the oxidation of model zinc ngers, we
have shown that H2O2 yields mainly disuldes as products at
physiological pH conditions whereas 1O2 yields mainly sul-
nates. Regarding kinetics, we have observed that neutral
Zn(Cys)2(His)2 zinc nger sites react slower with H2O2 than
negatively charged Zn(Cys)3(His) and Zn(Cys)4 zinc nger
sites.19,20 The reactivity of Zn$LASD(HHCC) toward H2O2 was
studied using the methodology previously described.19 Reaction
with H2O2 leads to disulde formation within the CEEC motif
with a second order rate constant of 0.030 ! 0.002 M"1 s"1 at
297 K. This is within the range of second order rate constants
determined for other Zn(Cys)2(His)2 zinc ngers (k ¼ 0.008–
0.037 M"1 s"1) but signicantly lower than for Zn(Cys)3(His)
and Zn(Cys)4 zinc ngers (k ¼ 0.1–1.5 M"1 s"1), conrming the
trend previously observed.20 Among Zn(Cys)2(His)2 zinc ngers
models, Zn$LASD(HHCC) reacts faster with H2O2 than Zn$CP-
1(CCHH) (k ¼ 0.008 M"1 s"1), a classical CCHH zinc nger
with well-dened bba fold. Regarding 1O2, reaction of
Zn$LASD(HHCC) is very fast leading to sulnates but over-
oxidation products (sulfonate, bis-sulnate) are also formed
very rapidly. No photooxidation of Zn2+-bound histidines was
detected, conrming that histidines are protected from 1O2
oxidation by Zn2+ coordination, as previously observed in the
case of a classical bba zinc nger.22 Unfortunately, all photo-
oxidation products could not be separated by HPLC precluding
precise determination of the chemical reaction rate constant
kr.21,22 This was not the case in previous studies. Indeed, the size
of the Zn$LASD(HHCC) model is large compared to our other
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previously described models (46 versus ca. 25 amino acids),
rendering HPLC separation less sensitive to changes occurring
at a single amino acid position. Hence, the size of the model
clearly matters for optimal separation and the smaller the
model, the more detailed the molecular information. Never-
theless, a lower limit of 3.9 # 106 M"1 s"1 could be determined
for kr. The observation of at least two overoxidation products –
even at short irradiation time – in the peak eluting at 20.3 min
(Fig. 5A) during analysis of photooxidation products of
Zn$LASD(HHCC) indicates that this kr value is probably under-
estimated. Hence, Zn$LASD(HHCC) reacts with 1O2 at least as fast
as, but most probably faster than, Zn$LTC (kr ¼ (4.3 ! 0.4) # 106
M"1 s"1), a Zn(Cys)4 treble clef zinc nger model, on contrary to
what is observed for H2O2. In the case of H2O2, negatively
charged Zn(Cys)4 sites react faster than neutral Zn(Cys)2(His)2
sites. Therefore, the observed trend for H2O2 regarding the
charge of the zinc nger site and its reactivity cannot be
extrapolated to 1O2 reactivity. The lower limit value of kr deter-
mined for Zn$LASD(HHCC) is higher than the kr value deter-
mined for Zn$CPF (kr ¼ (0.70 ! 0.07) # 106 M"1 s"1), a model
peptide for the CCHH classical bba zinc ngers, which diﬀers
from Zn$CP-1(CCHH) by a single Tyr to Phe mutation only. In
order to understand the greater reactivity of Zn$LASD(HHCC)
compared to the classical bba zinc nger CP-1/CPF observed for
H2O2 and 1O2, we have examined the structure of the
Zn(Cys)2(His)2 sites in both models focusing on two important
factors for cysteine sulfur reactivity: solvent accessible surface
and number of NH/S hydrogen bonds, the latter being known to
decrease the nucleophilic reactivity of Zn2+-bound sulfurs.23,46
Based on our NMR structure of Zn$LASD(HHCC) and the pdb le
1MEY47 for Zn$CP-1(CCHH), we found that the former has higher
sulfur solvent accessible surface area (8.8 A˚2 vs. 4.1 A˚2) and less
NH/S hydrogen bonds (1 vs. 3). Therefore, these two factors
support the greater reactivity of the anti-sigma factor domain zinc
nger model compared to the classical bba model.
Biological relevance
Zinc binding to ChrR and formation of the Zn(Cys)2(His)2 zinc
nger site of ChrR is needed to ensure its proper folding and
sequestering of sE.8 Plus, it was demonstrated that the anti-
sigma factor domain of ChrR is suﬃcient to sequester sE.10
Our data show that the Zn$LASD(HHCC) model can be oxidized
by 1O2 leading to its unfolding. This supports the hypothesis
that photooxidation of the cysteines of ChrR Zn(Cys)2(His)2 zinc
nger site may be a key event in the 1O2 sensing mechanism by
ChrR promoting the breakdown the ChrR–sE complex. Never-
theless, to be a sensing unit this zinc nger site would require
fast reaction with 1O2 in order to trigger quickly the cellular
response against 1O2 before too many oxidative damages are
produced. The kinetic data gained in this study are also in
favour of a sensing role for ChrR Zn(Cys)2(His)2 site: it reacts
with 1O2 faster than other known structural zinc nger sites,
either of the Zn(Cys)2(His)2 22 or Zn(Cys)4 21 type. Indeed, it
seems that the uncommon topology of the zinc nger site of
ChrR12 provides very high zinc aﬃnity while maintaining
“naked” cysteinates, with a low number of NH/S hydrogen
bonds, for higher reactivity. However, Rajasekar et al. have
shown that oxidation of the HHCC zinc nger of ZAS proteins is
not always suﬃcient to dissociate the anti-sigma factor from its
cognate sigma factor.17 In the case of ChrR, it was clearly
demonstrated that its C-terminal cupin-like domain is required
for the 1O2 response.10,11,17 Therefore, it is possible that 1O2
oxidation of both the zinc nger of ChrR anti-sigma factor
domain and essential histidine residues of the cupin-like domain
are required to cause suﬃcient conformational change to allow
the dissociation of the ChrR–sE complex. This would correspond
to a dual activation process making this system responsive to 1O2
only among ROS, for a specic triggering of the transcriptional
response. Alternatively, the essential histidine and glutamate
residues of the cupin-like domain (H141, H143, E147 and H177)
could provide alternative Zn2+ ligands to compensate for the
oxidized cysteines of the anti-sigma factor domain. A mixed
coordination set involving residues of both the anti-sigma
factor domain and the cupin-like domain around Zn2+ would
generate suﬃcient conformational rearrangement to destabi-
lize the ChrR–sE complex.
Conclusions
In this article, we have described the elaboration of a model for
the Zn(Cys)2(His)2 zinc nger site of the anti-sigma factor domain
of ChrR, a protein involved in transcriptional response to 1O2 in
several bacteria. This site has a special topology among zinc
ngers and its role in 1O2 sensing by ChrR is under debate. This
model, namely Zn$LASD(HHCC), is a 46-amino acid peptide
inspired from ChrR anti-sigma factor domain sequence. It forms
a 3-helix core when Zn2+ binds to the four cysteine and histidine
side chains. Zn$LASD(HHCC) adopts the same structure as the
corresponding sequence in ChrR anti-sigma factor domain. We
have shown that the cysteines of the Zn(Cys)2(His)2 site of
Zn$LASD(HHCC) are oxidized by 1O2 into sulnates and other
overoxidation products. Photooxidation is faster than that of
other zinc nger sites, especially compared to classical bba
Zn(Cys)2(His)2 zinc ngers. Additionally, 1O2 oxidation destabi-
lizes the zinc nger leading to its unfolding. The data presented in
this work indicate that photooxidation of the zinc nger site of
ChrR may be a key event in its 1O2 sensing mechanism.
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Abbreviations 
PyBOP: (Benzotriazol-1-yloxy)tripyrrolidino-phosphonium-hexafluorophosphate; Pd(PPh3)4: tetrakis(triphenyl-
phosphine)-palladium(0); TIS: triisopropylsilane; TCEP: tris(2-carboxyethyl)phosphine; DIEA: N,N-
diisopropylethylamine; TFA: trifluoroacetic acid; MeOH: methanol; DCM: dicholoromethane; Et2O: diethylether; 
DMF: N,N-dimethylformamide; tBu: tert-butyl; Trt: trityl; Fmoc: 9-fluorenylmethoxycarbonyl; Boc: tert-
butyloxycarbobyl; EDTA: ethylenediamine-tetraacetic acid; HPLC: high performance liquid chromatography; 
ESI: electrospray ionization; MS: mass spectrometry; UV-Vis: ultraviolet-visible; CD: circular dichroism. 
 
Materials and methods 
Reagents and solvents: N-α-Fmoc-protected amino acids for peptide synthesis, PyBOP coupling reagent and 
NovaPEG Rink Amide resin were obtained from Novabiochem. Other reagents for peptide synthesis, solvents, 
buffers and metal salts were purchased from Sigma-Aldrich. All buffers or metal solutions were prepared with 
MilliQ water (Millipore). Buffer solutions were treated with Chelex 100 resin (Biorad) to remove trace metal ions. 
The concentration of the Zn2+ and Co2+ stock solutions was determined by colorimetric EDTA titrations.[1] 
 
Analyses and purifications: RP-HPLC was used for analyses and purifications of the peptides. Mixtures of 
solvent A (0.1% TFA in H2O) and B (0.1% TFA in MeOH/H2O 9:1) were used as mobile phase. Analytical HPLC 
separations were performed on an Agilent Infinity 1200 system using Merck Chromolith RP-18e (150 mm ´ 4.6 
mm) columns. Method A consisted in 5% B during 2 min, a 5 to 55 % B linear gradient in 5 min, then a 55 to 90 
% B linear gradient in 15 min at 2 mL/min. Preparative HPLC separations were performed on a VWR LaPrepS 
system using a Waters XBridge Peptide BEH130 C18 (5 µm, 150 mm ´ 19 mm) column at 10 mL/min. The 
preparative separation method consisted in 5% B during 2 min, a 5 to 50 % B linear gradient in 5 min then a 50 to 
90 % B linear gradient in 25 min at 10 mL/min. Eluate was monitored by electronic absorption at 214, 254 and 
280. ESI-MS analyses were performed on a Thermo LXQ spectrometer. UV-Vis absorption spectra were recorded 
on a Perkin-Elmer Lambda 35 spectrophotometer or on a Varian Cary 50 spectrophotometer. Circular dichroism 
spectra were recorded on an Applied Photophysics Chirascan spectropolarimeter. 
 
Peptide synthesis 
Elongation of LASD(XHCC) Ac-KXVSKQLLKAYAEGTLSEAYSKKVAKHLSKCEECKAKAQKLKAKAA-
NH2 (with X = H or A) was performed on NovaPEG Rink Amide resin (0.40 mol g-1; 0.13 mmol scale) using 
standard SPPS protocols using Fmoc/tBu chemistry on an automated peptide synthesizer (CEM Liberty1 
Microwave Peptide Synthesizer) after attachment of the first amino acid by single manual coupling (30 min) using 
2-fold excess of Fmoc-Gly-OH, 2-fold excess of PyBOP and 6-fold excess of DIEA in DMF followed by 
acetylation using Ac2O/pyridine/DMF (1:2:7 (by vol.), 10 mL, 5 min). For automated synthesis, single coupling 
(5 min, 50°C, 25 W microwave power) were performed using 4-fold molar excess of Fmoc-L-amino acid, 4-fold 
molar excess of PyBOP and 8-fold molar excess of DIEA. A capping step was performed after each coupling with 
Ac2O/DIEA in DMF (5 min, 65 °C, 40 W microwave power). Fmoc removal was performed using 20% piperidine 
in DMF (30 s + 3 min, 70°C, 40 W microwave power). Dipeptides underlined in the above sequence were 
introduced as pseudo-proline dipeptides (Fmoc-Val-Ser(YMe,Mepro)-OH, Fmoc-Gly-Thr(YMe,Mepro)-OH, Fmoc-
Tyr(tBu)-Ser(YMe,Mepro)-OH and Fmoc-Leu-Ser(YMe,Mepro)-OH) by manual coupling as describe above for the 
 3 
first amino acid. Before the last two amino acids, the resin was divided into two parts in a 6:1 ratio. The KA 
terminus was assembled on the small batch and the KH terminus on the biggest. The N-terminus was acetylated 
manually using Ac2O/pyridine/DMF (1:2:7 (by vol.), 10 mL, 5 min). Removal of acid-labile protecting groups and 
resin cleavage were performed using TFA/H2O/TIS/DTT (19 mL:0.6 mL:0.6 mL:600 mg) for 2 h. TFA was 
evaporated under reduced pressure and cold Et2O was added to precipitate the peptide. The pure peptide was 
obtained after HPLC purification and freeze-drying. LASD(HHCC): Yield = 13 % (98 mg); HPLC (anal.) tR = 14.7 
min (method A); ESI-MS: average m/z = 1272.7 (4+), 1018.3 (5+), 848.8 (6+), 727.8 (7+), 636.9 (8+), 566.3 (9+), 
509.8 (10+) / calculated av. m/z = 1272.75 [M+4H]4+, 1018.40 [M+5H]5+, 848.84 [M+6H]6+, 727.72 [M+7H]7+, 
636.88 [M+8H]8+, 566.23 [M+9H]9+, 509.71 [M+10H]10+ for M = C225H383N65O64S2). LASD(AHCC): Yield = 13 
% (16 mg); HPLC (anal.) tR = 16.6 min (method A); ESI-MS: average m/z = 1256.1 (4+), 1005.0 (5+), 837.7 (6+), 
718.3 (7+), 628.7 (8+), 558.9 (9+) / calculated av. m/z = 1256.24 [M+4H]4+, 1005.19 [M+5H]5+, 837.83 [M+6H]6+, 
718.28 [M+7H]7+, 628.62 [M+8H]8+ , 558.89 [M+9H]9+  for M = C222H381N63O64S2). 
 
Fig. S1 HPLC chromatograms (left) and ESI-MS spectra (middle: full MS spectrum; right: experimental and 
simulated isotopic pattern of the [M+5H]5+ peak) of (A) LASD(HHCC) and (B) LASD(AHCC). 
 
Preparation of zinc finger stock solutions 
Solutions of metal-free LASD peptides (ca. 1 mM) were prepared by dissolution of the lyophilized peptides in H2O 
(or D2O for photooxidation experiments) under argon atmosphere. The exact peptide concentration was determined 
by Ellman’s assay.[2] Solutions of Zn·LASD (ca. 1 mM) complexes were prepared by adding 1.1 eq. of Zn2+ 
dissolved H2O (100 mM). The pH was adjusted to 7.0 using NaOH (or NaOD). 
 
Absorption and circular dichroism 
A solution of metal-free LASD peptide (10-20 µM and 100-150 µM for Zn2+ and Co2+ titrations, respectively) in 
phosphate buffer (20 mM, pH 7.0) containing TCEP (250 µM) was prepared from stock solutions of peptide, 
phosphate buffer (100 mM, pH 7.0) and TCEP (33 mM). Titrations were performed at 298 K under argon by 
adding aliquots of a degassed metal stock solution to a rubber-sealed quartz cell (0.4 cm or 1 cm path length) 
containing the peptide solution. UV-Vis spectra were recorded every 1 nm at a scan rate of 240 nm/min. CD 
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spectra were recorded from 300 nm to 200 nm every 1 nm with a 2 s signal averaging for each point. Each spectrum 
was recorded twice, averaged and smoothed using a Savitzky-Golay filter. 
 
Fig. S2 Assessment of Zn2+ binding constants by competition experiments. CD spectra of solutions containing 
LASD(HHCC) (A) or LASD(AHCC) (B) and one equivalent of EDTA in phosphate buffer (10 mM, pH 7.0) before 
addition of Zn2+ (solid lines) and after addition of 1.0 eq. Zn2+ (dotted lines) and 2.0 eq. Zn2+ (dashed lines). 
 
Oxidation by H2O2 
A solution of Zn·LASD(HHCC) (20 µM) and H2O2 (5-35 mM) was prepared in an appropriate buffer (pH 7.0) and 
the reaction was monitored by absorption spectrophotometry. Based on previous work, the decay of the LMCT 
band at 220 nm was used to monitor the reaction in phosphate buffer (100 mM).[3] The kinetic traces (Fig. S3A) 
could be fitted by mono-exponential to yield the apparent first-order rate constants, kobs. Fig. S3B shows the linear 
dependence of kobs against [H2O2], which yielded k = 0.031 ± 0.003 M-1 s-1. Fig. S3C shows the CD spectra 
recorded before introduction of H2O2 (1 mM) and after reaction (15 h). The PAR assay was thus used to confirm 
the value of k.[3] Oxidations were conducted in presence of PAR (100 µM) in Bis-Tris buffer 1(00 mM) and the 
appearance of Zn(PAR)2 absorption at 494 nm was recorded. Mono-exponential fit of the kinetic traces yielded 
kobs values, which were plotted against [H2O2] to yield k = 0.030 ± 0.001 M-1 s-1 (Fig. S3D). 
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Fig. S3 Oxidation of Zn·LASD(HHCC) by H2O2. (A) Kinetic traces (black, normalized) for the LMCT monitoring 
(220 nm) with mono-exponential fits in red. (B) Plot of kobs against [H2O2] for the LMCT monitoring. The solid 
line corresponds to the linear regression yielding k = 0.031 ± 0.003 M-1 s-1. (C) CD spectra recorded before (solid 
line) and after (dashed line) reaction with H2O2. (D) Kinetic traces (black, normalized) for the PAR monitoring 
(494 nm) with mono-exponential fits in red. (E) Plot of kobs against [H2O2] for the PAR monitoring. The solid line 
corresponds to the linear regression yielding k = 0.029 ± 0.001 M-1 s-1. 
 
Oxidation by 1O2 
Buffers: Deuterated buffer solutions were prepared by dissolving Na2HPO4 or ammonium acetate in D2O (99,9%  
from Eurisotop, traces of metals removed by passing D2O over CHELEX resin), and the pD was adjusted to 7.0 
or 8.0 (with a regular pH meter, pD = pHred + 0.44)[4] with NaOD and DCl. Otherwise, buffer solutions were 
prepared in milliQ H2O. 
Photooxidation: Typical photooxidation experiments were performed as follows. In an Eppendorf tube, the 
solution of Zn·LASD(HHCC) in D2O is diluted to 200 µM in buffer Pi 20 mM pD containing 1-3 µM photosensitizer 
(Rose Bengal or Methylene Blue). The sample is maintained at 278 K in a water-cooled bath in front of a 400 W 
halogen lamp. After ca. 5 min of temperature equilibration, irradiation is performed by turning the lamp on for 30 
seconds to 10 minutes, depending on the sample and solvent (shorter irradiation times are required for D2O solution 
compared to H2O). Then, the sample (100-300 µL) is injected into the HPLC for analysis. CD monitoring of the 
photooxidation was performed using H2O solutions. 
Determination of the lower limit for the photo-oxidation rate kr of Zn·LASD(HHCC): The competition 
experiments were conducted as previously described[5,6] using peptide EGWGK as a competitor. Photooxidation 
was performed following the photooxidation protocol described above, but in presence of methylene blue as 
photosensitizer and in 20 mM Pi pD 8.0. Consumption of the two competitors was monitored by integration of the 
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HPLC chromatograms obtained before and after irradiation. As noted in the text, the peak eluting at 20.3 min 
contains unreacted LASD(HHCC) as well as some oxidized peptides, but we considered that it contains 
LASD(HHCC) only. This led to underestimate the consumption of LASD(HHCC). The chemical reaction rate 
constant was calculated using the equation given in the article. Therefore, only a lower limit of kr was obtained: 
kr(Zn·LASD(HHCC)) < (3.9 ± 0.5)´106 M-1 s-1.  
ESI-MS analysis of photooxidation products: For ESI-MS analysis of the reaction mixture, Zn·LASD(HHCC) 
was photooxidized in ammonium acetate buffer (20 mM in D2O, pD 7.0) and the solution was lyophilized. The 
resulting solid was dissolved in H2O containing 0.1 % TFA and lyophilized three times for complete D/H exchange 
before ESI-MS analysis. Finally, the solid was dissolved in ammonium acetate (20 mM, pH 7.0) and analyzed by 
ESI-MS. For digestion experiments, products were separated by HPLC, collected and lyophilized. The two 
collected fractions (0.1-0.2 mg) were dissolved in ammonium acetate (20 mM, pH 7.0, 190 µL). Glutamate 
carboxypeptidase GluC (200 ng´µL-1, 10 µL) was added and solutions were incubated overnight at 37°C before 
freeze-drying. Fractions were dissolved in 0.1% TFA in H2O or ammonium acetate (with or without TCEP) and 
analyzed by ESI-MS. 
 
Table S1 ESI-MS analysis of GluC digested HPLC fractions of the photooxidation products of Zn·LASD(HHCC). 
Fragment Mass / Da Observed m/z / Da for [M+nH]n+ or [M–nH]n– species 
  peak eluting at 18.1 min peak eluting at 20.3 min 
Ac-KHVSKQLLKAYAE 
     unaltered 
 
1555.87 
 
1556.8 (1+), 779.3 (2+), 519.8 (3+),  
1554.6 (1–), 776.8 (2–), 1668.8 (1–) 
(M+CF3COO–) 
 
1556.8 (1+), 779.6 (2+) 
1554.6 (1–) 
AYSKKVAKHLSKC31EE 
     unaltered (CysSH) 
     sulfinic acid (CysSO2H) 
 
1719.90 
1751.89 
 
– 
877.2 (2+), 585.3 (3+) 
1750.8 (1–)*, 874.8 (2–), 931.6 (2–) 
(M+CF3COO–) 
 
861.1 (2+), 1718.8 (1–) 
– 
C34KAKAQKLKAKAA-NH2 
     unaltered (CysSH) 
 
     sulfinic acid (CysSO2H) 
     sulfonic acid (CysSO3H) 
 
1356.85 
 
1388.83 
1404.82 
 
1357.6 (1+), 679.3 (2+) 
1469.2 (1–) (M+CF3COO–) 
1387.6 (1–)* 
1403.5 (1–) 
 
1357.8 (1+), 679.6 (2+) 
1355.7 (1–) 
1387.5 (1–) 
1403.6 (1–) 
* loss of 66 mass units (H2SO2) in MS/MS fragmentation. 
 
Solution structure determination 
NMR spectroscopy: All NMR experiments were recorded on a 500 MHz Bruker AVANCE II spectrometer 
equipped with a BBI probe with a z-axis gradient field. Samples were prepared by adding 1.1 molar equivalent of 
Zn(ClO4)2 to the peptide (ca. 1.8 mM) in H2O/D2O 9:1. The pH was adjusted to 6.3 with NaOH and HCl. 1D 1H 
NMR spectra were recorded with 12-ppm window and 32k data points in the time domain. 2D 1H-1H spectra were 
acquired with Watergate[7,8] solvent suppression in phase-sensitive mode using 4096´1024 matrices over a 5000 
Hz spectral width. TOCSY experiments were recorded at 298 K and 283 K using a MLEV-17 spin-lock sequence 
with a 70 ms mixing time. NOESY experiments were recorded at 298 K with a 200 ms mixing time. DQF-COSY 
spectra were recorded at 298 K. All spectra were processed with TOPSPIN 3.2. 
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Structure calculations: Cross peaks in NOESY spectra were integrated using the program SPARKY 3.114[9] and 
converted to H-H distances. Tyr Hd/He (2.44 Å), Leu Hg/Hd, Thr Hb/Hg, Val Hb/Hg (2.80 Å) and His He1/Hd2 
(4.21 Å) were used as references for distance calibrations. Multiplicity was taken into account. Upper distance 
restraints were set to 2.7 Å, 3.5 Å, 5.0 Å and 7.0 Å for distances £ 2.5 Å, £ 3.3 Å, £ 4.8 Å and ³ 4.8 Å, respectively. 
3JHN,Ha coupling constants were measured on 1D 1H NMR spectra experiments. f dihedral restraints were derived 
from 3JHN,Ha. Non-stereospecifically assigned protons were treated as pseudo-atoms. All peptide bond w angles 
were set to trans. Solution structures were calculated using the program X-PLOR 3.851[10] following standard 
refinement protocols starting from random structures with r-6 averaging. The non-bonded interactions were 
modeled by the PARALLHDG force field. A first calculation was performed not including the zinc ion in the 
topology file to determine the overall fold of the peptide. The structure revealed the folding of helix H1, H2 and 
H3 and their close packing. The side chains of the two His and the two Cys residues were also very close, indicating 
their binding to the zinc ion. This calculation ensured that introducing a tetrahedral Zn(Cys)2(His)2 core in the 
topology file would not bias the structure. It also allowed determining which His N was bound to zinc. In house 
modifications were thus incorporated in the topology and parameter files (topallhdg.pro and parallhdg.pro) to 
account for for zinc binding to cysteines and histidines in a tetrahedral geometry with 2.33 Å and 2.00 Zn-S and 
Zn-N bonds, respectively, 109.4°, 109.4°, 105° and 125° S-Zn-S and S-Zn-N, Zn-S-C and Zn-N-C angles, 
respectively. Structures selected for analysis had no NOE violations greater than 0.2 Å and no dihedral angle 
violations greater than 5°.  
 
 
Fig. S4 Summary of 1H NMR data for Zn·LASD(HHCC) in H2O/D2O 9:1 (pH 6.4) at 298 K. 
 
 
Table S2 1H NMR (500 MHz) coupling constants (3JHN,Ha / Hz) and chemical shifts (d / ppm) for Zn·LASD(HHCC) 
in H2O/D2O 9:1 (pH 6.4) at 298 K.a 
Residue 3JHN,Ha d(HN) d(Ha) d(Hb) d(others) 
Ac – – 2.018   
LYS 1 n.d. 8.040 4.100 1.576, 1.649 CH2(g): 1.340; CH2(d): 1.357; CH2(e): 3.008 
HIS 2 n.d. 7.830 4.300 2.797, 2.902  
VAL 3 7.0 6.930 3.960 1.983 CH3(g): 1.065, 1.148 
SER 4 < 4 8.172 4.353 4.095  
LYS 5 4.2 8.867 3.936 1.871, 1.972 CH2(g): 1.521; CH2(d): 1.752; CH2(e): 3.024 
GLN 6 4.0 8.556 4.032 2.004, 2.111 CH2(g): 2.477; NH(e): 6.908, 7.552 
LEU 7 7.9 7.623 4.200 1.294, 1.908 CH2(g): 1.562; CH3(d): 0.736, 0.898 
LEU 8 < 5 8.484 4.026 1.412, 1.875 CH2(g): 1.736; CH3(d): 0.873, 0.942 
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LYS 9 4.1 8.109 3.967 1.880, 1.937 CH2(g): 1.358, 1.481; CH2(d): 1.700; CH2(e): 3.036 
ALA 10 < 4 7.528 4.194 1.445  
TYR 11 2.5 8.791 4.175 3.192, 3.387 CH(d): 6.989; CH(e): 6.866 
ALA 12 3.7 8.608 3.893 1.574  
GLU 13 7.9 8.190 4.183 2.088, 2.157 CH2(g): 2.328, 2.599 
GLY 14 – 7.819 3.979, 
4.100 
  
THR 15 9.7 8.264 4.440 4.541 CH3(g): 1.117 
LEU 16 7.2 7.417 4.545 1.752 CH2(g): 1.747; CH3(d): 0.965, 1.085 
SER 17 3.7 8.598 4.486 4.167, 4.368  
GLU 18 2.7 9.130 4.157 2.094, 2.183 CH2(g): 2.302, 2.416 
ALA 19 2.8 8.572 4.106 1.350  
TYR 20 7.4 7.696 4.423 3.089 CH(d): 7.211; CH(e): 6.899 
SER 21 3.1 9.094 4.229 4.144  
LYS 22 3.7 8.169 4.155 1.953 CH2(g): 1.519; CH2(d): 1.736; CH2(e): 3.025 
LYS 23 5.4 7.335 4.064 1.983 CH2(g): 1.424; CH2(d): 1.624; CH2(e): 2.896 
VAL 24 4.3 8.278 3.480 1.992 CH3(g): 0.355, 1.040 
ALA 25 2.5 8.666 3.776 1.639  
LYS 26 5.0 7.866 4.103 1.978 CH2(g): 1.544; CH2(d): 1.725; CH2(e): 3.009 
HIS 27 5.9 7.675 4.321 3.230, 3.284 CH(d), 6.893; CH(e): 7.833 
LEU 28 3.1 8.526 3.854 1.396, 1.799 CH2(g): 1.767; CH3(d): 0.636 
SER 29 < 5 7.612 4.198 4.029  
LYS 30 9.9 7.073 4.628 1.711, 1.950 CH2(g): 1.362; CH2(d): 1.610; CH2(e): 2.860 
CYS 31 9.1 7.525 4.643 1.858, 2.519  
GLU 32 3.7 8.993 4.087 2.075, 2.165 CH2(g): 2.385, 2.453 
GLU 33 n.d. 8.381 4.191 1.936 CH2(g): 2.242 
CYS 34 5.6 9.284 4.117 2.868, 3.135  
LYS 35 < 6 8.378 3.867 1.926, 2.231 CH2(g): 1.569; CH2(d): 1.412; CH2(e): 2.949 
ALA 36 4.1 8.140 4.249 1.575  
LYS 37 < 6 7.608 4.010 1.872, 2.025 CH2(g): 1.434; CH2(d): 1.745; CH2(e): 2.928 
ALA 38 < 6 8.487 4.047 1.649  
GLN 39 n.d. 8.240 4.071 2.198, 2.302 CH2(g): 2.508, 2.636; NH(e): 6.931, 7.467 
LYS 40 5.3 7.769 4.174 1.991 CH2(g): 1.523; CH2(d): 1.690; CH2(e): 3.015 
LEU 41 < 6 7.849 4.169 1.493 CH2(g): 1.888; CH3(d): 0.862, 0.911 
LYS 42 5.8 7.961 4.249 1.909 CH2(g): 1.572; CH2(d): 1.728; CH2(e): 3.033 
ALA 43 5.6 7.998 4.310 1.472  
LYS 44 < 6 8.025 4.085 1.915, 1.990 CH2(g): 1.591; CH2(d): 1.738; CH2(e): 3.007 
ALA 45 5.0 7.935 4.276 1.509  
ALA 46 > 6 8.045 4.284 1.469  
 a Chemical shifts are measured relative to external DSS. 
 
 
Table S3 NOE-derived distances (Å) used for calculations with X-PLOR for Zn·LASD(HHCC). 
LYS 1 HN LYS 1 HA 3.35  LYS 22 HN LYS 22 HD* 2.90 
LYS 1 HN HIS 2 HN 3.48  LYS 22 HN LYS 23 HN 2.74 
HIS 2 HD2 LYS 1 HA 3.99  LYS 23 HB* TYR 20 HA 2.98 
HIS 2 HD2 LYS 1 HB* 4.24  LYS 23 HN TYR 20 HA 3.13 
HIS 2 HN LYS 1 HA 2.31  LYS 23 HN SER 21 HA 4.03 
HIS 2 HB* HIS 2 HA 2.73  LYS 23 HN LYS 22 HA 3.27 
HIS 2 HD2 HIS 2 HA 3.91  LYS 23 HN LYS 22 HB* 3.41 
HIS 2 HD2 HIS 2 HB* 2.86  LYS 23 HN LYS 23 HA 2.74 
HIS 2 HE1 HIS 2 HN 3.37  LYS 23 HN LYS 23 HB* 2.57 
HIS 2 HN HIS 2 HA 3.70  LYS 23 HN LYS 23 HD* 3.67 
HIS 2 HN HIS 2 HB* 2.78  LYS 23 HN LYS 23 HG* 4.02 
HIS 2 HN HIS 2 HD2 3.39  LYS 23 HN VAL 24 HG* 5.14 
HIS 2 HN VAL 3 HN 3.57  VAL 24 HG* VAL 3 HG* 5.42 
VAL 3 HG* HIS 2 HA 4.72  VAL 24 HG* LEU 8 HA 4.53 
VAL 3 HG* HIS 2 HB* 4.97  VAL 24 HG* LEU 8 HD* 4.89 
VAL 3 HN HIS 2 HA 2.48  VAL 24 HG* TYR 11 HA 4.18 
 9 
VAL 3 HN HIS 2 HB* 2.63  VAL 24 HG* TYR 11 HB* 3.71 
VAL 3 HG* VAL 3 HA 3.30  VAL 24 HG* LEU 16 HB* 4.24 
VAL 3 HN VAL 3 HA 2.94  VAL 24 HG* TYR 20 HA 5.37 
VAL 3 HN VAL 3 HB 2.60  VAL 24 HG* SER 21 HA 4.15 
VAL 3 HN VAL 3 HG* 3.40  VAL 24 HN SER 21 HA 3.14 
VAL 3 HG* LEU 7 HB* 4.05  VAL 24 HN LYS 23 HA 2.80 
VAL 3 HG* LEU 8 HA 4.64  VAL 24 HN LYS 23 HN 2.61 
VAL 3 HG* LEU 8 HG 4.09  VAL 24 HB VAL 24 HA 2.83 
VAL 3 HG* VAL 24 HA 3.67  VAL 24 HG* VAL 24 HA 3.06 
VAL 3 HG* HIS 27 HB* 4.14  VAL 24 HN VAL 24 HA 2.82 
SER 4 HN VAL 3 HA 2.23  VAL 24 HN VAL 24 HB 2.22 
SER 4 HN VAL 3 HG* 3.67  VAL 24 HN VAL 24 HG* 3.23 
SER 4 HN SER 4 HA 2.63  VAL 24 HG* ALA 25 HA 4.70 
SER 4 HN SER 4 HB* 2.50  VAL 24 HG* ALA 25 HB* 4.69 
SER 4 HN LEU 7 HD* 5.79  VAL 24 HN ALA 25 HB* 3.68 
SER 4 HN LEU 7 HN 3.54  VAL 24 HG* LEU 28 HD* 4.04 
SER 4 HN LEU 8 HD* 4.27  ALA 25 HN TYR 11 HD* 4.48 
LYS 5 HN SER 4 HA 2.51  ALA 25 HN TYR 11 HE* 3.90 
LYS 5 HN SER 4 HB* 3.88  ALA 25 HN SER 21 HA 3.70 
LYS 5 HN SER 4 HN 4.28  ALA 25 HB* LYS 22 HA 3.01 
LYS 5 HN LYS 5 HA 3.07  ALA 25 HN LYS 22 HA 3.16 
LYS 5 HN LYS 5 HB* 3.03  ALA 25 HN LYS 23 HA 4.16 
LYS 5 HN LYS 5 HG* 4.03  ALA 25 HN LYS 23 HN 3.89 
LYS 5 HN GLN 6 HN 3.39  ALA 25 HN VAL 24 HA 3.39 
GLN 6 HN SER 4 HA 3.58  ALA 25 HN VAL 24 HB 2.56 
GLN 6 HN LYS 5 HA 3.45  ALA 25 HN VAL 24 HG* 3.92 
GLN 6 HN LYS 5 HB* 2.93  ALA 25 HN VAL 24 HN 2.69 
GLN 6 HN GLN 6 HA 2.77  ALA 25 HN ALA 25 HA 2.79 
GLN 6 HN GLN 6 HB* 2.84  ALA 25 HN ALA 25 HB* 2.87 
GLN 6 HN GLN 6 HG* 3.71  ALA 25 HN LYS 26 HN 2.79 
GLN 6 HN LEU 7 HN 2.77  ALA 25 HN HIS 27 HN 4.13 
LEU 7 HN VAL 3 HG* 4.96  ALA 25 HN LEU 28 HD* 5.45 
LEU 7 HD* SER 4 HA 4.65  LYS 26 HN ALA 25 HA 3.37 
LEU 7 HN GLN 6 HB* 2.95  LYS 26 HN ALA 25 HB* 3.16 
LEU 7 HB* LEU 7 HA 2.81  LYS 26 HN LYS 26 HA 2.85 
LEU 7 HD* LEU 7 HA 3.45  LYS 26 HN LYS 26 HB* 2.43 
LEU 7 HN LEU 7 HA 3.08  LYS 26 HN HIS 27 HN 2.69 
LEU 7 HN LEU 7 HB* 2.66  HIS 27 HD2 HIS 2 HA 3.09 
LEU 7 HN LEU 7 HD* 4.21  HIS 27 HE1 HIS 2 HA 2.72 
LEU 7 HN LEU 7 HG 3.31  HIS 27 HD2 VAL 3 HA 3.82 
LEU 7 HD* TYR 20 HB* 5.56  HIS 27 HD2 VAL 3 HB 3.35 
LEU 8 HN VAL 3 HG* 4.13  HIS 27 HD2 VAL 3 HG* 3.49 
LEU 8 HD* LYS 5 HA 3.92  HIS 27 HE1 VAL 3 HG* 6.12 
LEU 8 HN LYS 5 HA 3.07  HIS 27 HN VAL 3 HG* 4.87 
LEU 8 HN LEU 7 HA 3.26  HIS 27 HD2 LEU 8 HD* 5.08 
LEU 8 HN LEU 7 HB* 3.60  HIS 27 HD2 VAL 24 HA 4.31 
LEU 8 HN LEU 7 HG 3.34  HIS 27 HD2 VAL 24 HG* 5.62 
LEU 8 HN LEU 7 HN 2.42  HIS 27 HN VAL 24 HA 3.25 
LEU 8 HD* LEU 8 HA 3.09  HIS 27 HN VAL 24 HG* 5.68 
LEU 8 HN LEU 8 HB* 2.69  HIS 27 HN LYS 26 HB* 2.93 
LEU 8 HN LEU 8 HD* 3.63  HIS 27 HB* HIS 27 HA 2.69 
LEU 8 HN LEU 8 HG 2.55  HIS 27 HD2 HIS 27 HB* 3.07 
LEU 8 HN LYS 9 HN 2.65  HIS 27 HN HIS 27 HA 2.85 
LEU 8 HN ALA 10 HN 3.74  HIS 27 HN HIS 27 HB* 2.59 
LEU 8 HD* CYS 34 HB* 4.59  HIS 27 HD2 LEU 28 HA 3.47 
LYS 9 HN LEU 7 HN 3.40  HIS 27 HD2 LEU 28 HD* 3.69 
LYS 9 HN LEU 8 HA 2.93  HIS 27 HD2 LEU 28 HG 3.94 
LYS 9 HN LEU 8 HD* 5.09  HIS 27 HN LEU 28 HD* 5.17 
LYS 9 HN LYS 9 HA 2.64  HIS 27 HD2 CYS 31 HB* 3.35 
LYS 9 HN LYS 9 HB* 2.37  HIS 27 HE1 CYS 31 HB* 3.48 
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LYS 9 HN ALA 10 HN 2.72  HIS 27 HD2 CYS 34 HA 3.82 
LYS 9 HN LEU 41 HD* 4.09  HIS 27 HD2 CYS 34 HB* 2.69 
ALA 10 HN GLN 6 HA 3.33  LEU 28 HN VAL 3 HG* 5.28 
ALA 10 HN LYS 9 HA 3.30  LEU 28 HN VAL 24 HA 3.86 
ALA 10 HN LYS 9 HB* 2.89  LEU 28 HN VAL 24 HG* 5.10 
ALA 10 HN ALA 10 HA 2.54  LEU 28 HD* ALA 25 HA 3.86 
ALA 10 HN ALA 10 HB* 2.40  LEU 28 HG ALA 25 HA 2.50 
ALA 10 HB* LEU 16 HA 4.05  LEU 28 HN ALA 25 HA 3.15 
ALA 10 HN LEU 16 HD* 4.88  LEU 28 HN LYS 26 HN 3.93 
TYR 11 HE* VAL 3 HG* 4.92  LEU 28 HN HIS 27 HA 3.81 
TYR 11 HB* LEU 8 HA 2.76  LEU 28 HN HIS 27 HB* 2.99 
TYR 11 HD* LEU 8 HA 3.64  LEU 28 HN HIS 27 HD2 3.96 
TYR 11 HD* LEU 8 HD* 5.57  LEU 28 HN HIS 27 HN 2.64 
TYR 11 HN LEU 8 HA 3.15  LEU 28 HB* LEU 28 HA 2.84 
TYR 11 HN LYS 9 HA 3.98  LEU 28 HD* LEU 28 HA 2.99 
TYR 11 HN LYS 9 HN 4.00  LEU 28 HD* LEU 28 HB* 3.61 
TYR 11 HN ALA 10 HA 3.08  LEU 28 HN LEU 28 HA 2.80 
TYR 11 HN ALA 10 HB* 3.40  LEU 28 HN LEU 28 HB* 3.25 
TYR 11 HN ALA 10 HN 2.74  LEU 28 HN LEU 28 HD* 3.73 
TYR 11 HB* TYR 11 HA 2.62  LEU 28 HN LEU 28 HG 2.24 
TYR 11 HD* TYR 11 HA 2.76  LEU 28 HN SER 29 HN 2.73 
TYR 11 HD* TYR 11 HB* 2.78  LEU 28 HN LYS 30 HN 4.22 
TYR 11 HE* TYR 11 HB* 3.63  LEU 28 HD* CYS 31 HB* 5.58 
TYR 11 HN TYR 11 HA 2.77  LEU 28 HD* CYS 34 HA 4.76 
TYR 11 HN TYR 11 HB* 2.49  LEU 28 HD* CYS 34 HB* 3.54 
TYR 11 HN TYR 11 HD* 3.76  LEU 28 HD* LYS 35 HB* 5.32 
TYR 11 HD* ALA 12 HA 3.56  LEU 28 HD* ALA 38 HB* 3.82 
TYR 11 HD* ALA 12 HB* 4.44  SER 29 HN ALA 25 HA 3.73 
TYR 11 HE* ALA 12 HA 4.12  SER 29 HN LYS 26 HA 2.68 
TYR 11 HE* ALA 12 HB* 5.21  SER 29 HN LEU 28 HA 3.16 
TYR 11 HN ALA 12 HB* 4.65  SER 29 HN LEU 28 HB* 4.02 
TYR 11 HN ALA 12 HN 2.73  SER 29 HN LEU 28 HD* 4.75 
TYR 11 HN GLU 13 HN 4.08  SER 29 HN SER 29 HA 2.65 
TYR 11 HD* LEU 16 HD* 3.96  SER 29 HN SER 29 HB* 2.70 
TYR 11 HD* LEU 16 HG 3.59  SER 29 HN LYS 30 HN 2.64 
TYR 11 HE* LEU 16 HD* 5.73  LYS 30 HN HIS 27 HA 3.51 
TYR 11 HN LEU 16 HD* 3.99  LYS 30 HN LEU 28 HA 3.53 
TYR 11 HN LEU 16 HG 3.42  LYS 30 HN SER 29 HA 3.34 
TYR 11 HD* SER 21 HA 3.02  LYS 30 HN SER 29 HB* 3.70 
TYR 11 HE* SER 21 HA 3.51  LYS 30 HB* LYS 30 HA 2.62 
TYR 11 HE* SER 21 HB* 3.45  LYS 30 HN LYS 30 HB* 2.83 
TYR 11 HD* VAL 24 HB 3.22  LYS 30 HN LYS 30 HG* 3.25 
TYR 11 HD* VAL 24 HG* 4.06  LYS 30 HN CYS 31 HB* 3.81 
TYR 11 HE* VAL 24 HB 3.64  CYS 31 HB* LEU 28 HA 3.43 
TYR 11 HE* VAL 24 HG* 4.95  CYS 31 HN LEU 28 HA 3.03 
TYR 11 HN VAL 24 HG* 4.24  CYS 31 HN LYS 30 HB* 3.39 
TYR 11 HE* ALA 25 HA 4.11  CYS 31 HN LYS 30 HN 2.20 
TYR 11 HE* ALA 25 HB* 3.53  CYS 31 HB* CYS 31 HA 2.63 
TYR 11 HD* LEU 28 HD* 4.61  CYS 31 HN CYS 31 HB* 2.61 
TYR 11 HE* LEU 28 HD* 4.05  CYS 31 HB* CYS 34 HB* 3.12 
TYR 11 HD* ALA 38 HB* 3.91  GLU 32 HN CYS 31 HA 2.24 
ALA 12 HN LEU 8 HA 3.38  GLU 32 HN CYS 31 HB* 3.98 
ALA 12 HB* LYS 9 HA 3.26  GLU 32 HN CYS 31 HN 3.83 
ALA 12 HN LYS 9 HA 3.21  GLU 32 HN GLU 32 HA 2.83 
ALA 12 HN ALA 10 HN 4.27  GLU 32 HN GLU 32 HB* 2.71 
ALA 12 HN TYR 11 HB* 2.74  GLU 32 HN GLU 32 HG* 3.21 
ALA 12 HN TYR 11 HD* 3.50  GLU 32 HN GLU 33 HN 2.74 
ALA 12 HN ALA 12 HA 2.82  GLU 33 HN CYS 31 HA 3.22 
ALA 12 HN ALA 12 HB* 2.86  GLU 33 HN CYS 31 HN 4.25 
ALA 12 HN GLU 13 HN 2.72  GLU 33 HN GLU 32 HB* 2.56 
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ALA 12 HN GLY 14 HN 3.85  GLU 33 HN GLU 33 HA 2.65 
ALA 12 HN VAL 24 HG* 5.41  GLU 33 HN GLU 33 HB* 3.21 
ALA 12 HN LEU 41 HD* 5.22  CYS 34 HN LEU 8 HD* 6.05 
GLU 13 HN ALA 12 HA 3.36  CYS 34 HN HIS 27 HD2 3.93 
GLU 13 HN ALA 12 HB* 3.01  CYS 34 HB* LEU 28 HA 3.53 
GLU 13 HG* GLU 13 HA 3.46  CYS 34 HN LEU 28 HD* 5.03 
GLU 13 HN GLU 13 HA 2.74  CYS 34 HN CYS 31 HA 3.94 
GLU 13 HN GLU 13 HB* 2.60  CYS 34 HN CYS 31 HB* 3.47 
GLU 13 HN GLU 13 HG* 2.79  CYS 34 HN GLU 32 HN 4.15 
GLU 13 HN GLY 14 HN 2.54  CYS 34 HN GLU 33 HA 3.42 
GLY 14 HN GLU 13 HA 2.79  CYS 34 HN GLU 33 HB* 3.14 
GLY 14 HN GLY 14 HA* 2.53  CYS 34 HN GLU 33 HG* 4.09 
THR 15 HG* ALA 10 HA 4.48  CYS 34 HN GLU 33 HN 2.36 
THR 15 HN ALA 10 HA 2.81  CYS 34 HB* CYS 34 HA 2.67 
THR 15 HN ALA 10 HB* 3.71  CYS 34 HN CYS 34 HA 2.77 
THR 15 HG2* GLU 13 HB* 3.73  CYS 34 HN CYS 34 HB* 2.65 
THR 15 HN GLY 14 HA1 2.98  CYS 34 HN LYS 35 HA 3.88 
THR 15 HN GLY 14 HN 2.55  CYS 34 HN ALA 36 HN 4.02 
THR 15 HG2* THR 15 HA 3.04  CYS 34 HN LYS 37 HN 4.25 
THR 15 HN THR 15 HA 2.81  LYS 35 HN LEU 28 HD* 4.33 
THR 15 HN THR 15 HB 3.37  LYS 35 HN GLU 32 HA 2.69 
THR 15 HN THR 15 HG2* 3.28  LYS 35 HN CYS 34 HB* 3.08 
THR 15 HN LEU 16 HG 2.93  LYS 35 HB* LYS 35 HA 2.91 
THR 15 HN LEU 16 HN 2.46  LYS 35 HN LYS 35 HA 2.69 
LEU 16 HD* ALA 10 HB* 4.00  LYS 35 HN LYS 35 HB* 2.46 
LEU 16 HN ALA 10 HB* 4.20  LYS 35 HN LYS 35 HG* 3.80 
LEU 16 HD* TYR 11 HA 3.10  LYS 35 HN ALA 36 HN 2.67 
LEU 16 HD* TYR 11 HB* 3.98  LYS 35 HN LYS 37 HN 3.77 
LEU 16 HN TYR 11 HA 3.21  ALA 36 HN GLU 32 HA 3.15 
LEU 16 HN THR 15 HA 3.11  ALA 36 HB* GLU 33 HA 2.89 
LEU 16 HN THR 15 HG2* 4.51  ALA 36 HN GLU 33 HA 3.77 
LEU 16 HB* LEU 16 HA 2.60  ALA 36 HN LYS 35 HA 3.18 
LEU 16 HD* LEU 16 HA 3.67  ALA 36 HN LYS 35 HB* 2.73 
LEU 16 HN LEU 16 HA 2.80  ALA 36 HN ALA 36 HA 2.87 
LEU 16 HN LEU 16 HD* 4.05  ALA 36 HN ALA 36 HB* 2.79 
LEU 16 HD* TYR 20 HA 4.33  ALA 36 HN LYS 37 HN 2.73 
LEU 16 HD* TYR 20 HB* 3.47  LYS 37 HN LEU 8 HD* 4.84 
LEU 16 HD* SER 21 HA 3.70  LYS 37 HN ALA 36 HA 3.12 
SER 17 HN ALA 10 HB* 4.57  LYS 37 HN ALA 36 HB* 3.34 
SER 17 HN LEU 16 HA 2.29  LYS 37 HN LYS 37 HB* 2.92 
SER 17 HN LEU 16 HB* 2.91  LYS 37 HN LYS 37 HG* 2.91 
SER 17 HN LEU 16 HD* 3.75  LYS 37 HN ALA 38 HB* 4.17 
SER 17 HN LEU 16 HN 3.84  ALA 38 HN LEU 28 HD* 4.51 
SER 17 HN SER 17 HA 2.89  ALA 38 HB* LYS 35 HA 3.24 
SER 17 HN SER 17 HB* 2.79  ALA 38 HN LYS 35 HA 3.19 
SER 17 HN TYR 20 HB* 3.48  ALA 38 HN LYS 37 HB* 2.83 
SER 17 HN TYR 20 HD* 4.85  ALA 38 HN LYS 37 HB* 2.92 
SER 17 HN TYR 20 HN 3.88  ALA 38 HN LYS 37 HN 3.01 
GLU 18 HN SER 17 HA 2.66  ALA 38 HN ALA 38 HA 2.41 
GLU 18 HN SER 17 HB* 3.46  ALA 38 HN ALA 38 HB* 2.89 
GLU 18 HN SER 17 HN 4.53  ALA 38 HN GLN 39 HN 2.67 
GLU 18 HN GLU 18 HA 2.75  ALA 38 HN LYS 40 HN 3.86 
GLU 18 HN GLU 18 HB* 2.94  GLN 39 HN ALA 36 HA 2.72 
GLU 18 HN GLU 18 HG* 3.99  GLN 39 HN ALA 36 HB* 4.05 
GLU 18 HN ALA 19 HB* 5.19  GLN 39 HN ALA 38 HB* 3.26 
GLU 18 HN ALA 19 HN 3.64  GLN 39 HN GLN 39 HA 2.59 
ALA 19 HN GLU 18 HA 3.24  GLN 39 HN GLN 39 HB* 2.66 
ALA 19 HN GLU 18 HB* 3.19  GLN 39 HN GLN 39 HB* 3.11 
ALA 19 HN ALA 19 HA 2.82  GLN 39 HN LYS 40 HN 2.70 
ALA 19 HN ALA 19 HB* 3.02  LYS 40 HN LYS 37 HA 2.95 
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ALA 19 HB* TYR 20 HA 4.55  LYS 40 HN GLN 39 HA 3.20 
ALA 19 HN TYR 20 HN 2.92  LYS 40 HN GLN 39 HB* 3.05 
TYR 20 HD* LEU 7 HD* 4.96  LYS 40 HN LYS 40 HA 2.67 
TYR 20 HE* LEU 7 HD* 5.26  LYS 40 HN LYS 40 HB* 2.64 
TYR 20 HB* LEU 16 HA 3.92  LEU 41 HD* LEU 8 HB* 3.72 
TYR 20 HD* LEU 16 HD* 5.00  LEU 41 HD* LYS 9 HA 3.59 
TYR 20 HN LEU 16 HD* 5.18  LEU 41 HD* LYS 9 HE* 5.15 
TYR 20 HN GLU 18 HA 3.41  LEU 41 HD* ALA 12 HB* 4.49 
TYR 20 HD* ALA 19 HB* 5.02  LEU 41 HD* ALA 38 HA 3.77 
TYR 20 HN ALA 19 HB* 3.36  LEU 41 HN ALA 38 HA 2.78 
TYR 20 HB* TYR 20 HA 2.68  LEU 41 HD* LEU 41 HA 3.61 
TYR 20 HD* TYR 20 HA 3.90  LEU 41 HD* LEU 41 HB* 4.00 
TYR 20 HD* TYR 20 HB* 4.34  LEU 41 HN LEU 41 HA 2.66 
TYR 20 HN TYR 20 HA 2.85  LEU 41 HN LEU 41 HB* 3.05 
TYR 20 HN TYR 20 HB* 2.70  LEU 41 HN LEU 41 HD* 3.55 
TYR 20 HN TYR 20 HD* 4.25  LEU 41 HN LEU 41 HG 2.29 
TYR 20 HD* VAL 24 HG* 5.68  LYS 42 HN LEU 41 HA 4.31 
SER 21 HN TYR 11 HD* 5.06  LYS 42 HN LYS 42 HA 2.77 
SER 21 HN LEU 16 HD* 4.48  LYS 42 HN ALA 45 HB* 4.18 
SER 21 HN LEU 16 HN 4.85  ALA 43 HN GLN 39 HA 3.55 
SER 21 HN SER 17 HN 4.43  ALA 43 HB* LYS 40 HA 2.79 
SER 21 HN ALA 19 HA 3.73  ALA 43 HN LYS 42 HA 2.98 
SER 21 HN ALA 19 HB* 4.87  ALA 43 HN LYS 42 HB* 3.20 
SER 21 HN ALA 19 HN 4.21  ALA 43 HN ALA 43 HA 3.08 
SER 21 HN TYR 20 HA 3.35  ALA 43 HN ALA 43 HB* 3.44 
SER 21 HN TYR 20 HB* 3.19  LYS 44 HN LYS 40 HA 3.33 
SER 21 HN TYR 20 HD* 5.66  LYS 44 HN LEU 41 HA 3.33 
SER 21 HN TYR 20 HN 2.54  LYS 44 HN LEU 41 HD* 5.00 
SER 21 HN SER 21 HA 2.82  LYS 44 HN LYS 44 HA 2.52 
SER 21 HN SER 21 HB* 2.74  LYS 44 HN LYS 44 HB* 2.53 
SER 21 HN LYS 22 HN 2.84  ALA 45 HB* LEU 41 HA 2.86 
SER 21 HN LYS 23 HN 4.00  ALA 45 HN LEU 41 HA 2.95 
SER 21 HN VAL 24 HG* 6.08  ALA 45 HN LYS 44 HA 2.69 
SER 21 HN VAL 24 HN 4.62  ALA 45 HN LYS 44 HB* 3.31 
LYS 22 HN TYR 20 HN 3.80  ALA 45 HN ALA 45 HA 2.87 
LYS 22 HN LYS 22 HA 2.59  ALA 45 HN ALA 45 HB* 2.87 
LYS 22 HN LYS 22 HB* 2.63  ALA 46 HN ALA 46 HB* 3.65 
 
 
Table S4 Dihedral angle restraints (°) used in calculations with X-PLOR for Zn·LASD(HHCC). 
VAL 3 C SER 4 N SER 4 CA SER 4 C -65 -90 -40 
SER 4 C LYS 5 N LYS 5 CA LYS 5 C -65 -90 -40 
LYS 5 C GLN 6 N GLN 6 CA GLN 6 C -65 -90 -40 
LEU 7 C LEU 8 N LEU 8 CA LEU 8 C -65 -90 -40 
SER 8 C LYS 9 N LYS 9 CA LYS 9 C -65 -90 -40 
LYS 9 C ALA 10 N ALA 10 CA ALA 10 C -65 -90 -40 
ALA 10 C TYR 11 N TYR 11 CA TYR 11 C -65 -90 -40 
TYR 11 C ALA 12 N ALA 12 CA ALA 12 C -65 -90 -40 
GLY 14 C THR 15 N THR 15 CA THR 15 C -120 -160 -80 
LEU 16 C SER 17 N SER 17 CA SER 17 C -65 -90 -40 
SER 17 C GLU 18 N GLU 18 CA GLU 18 C -65 -90 -40 
GLU 18 C ALA 19 N ALA 19 CA ALA 19 C -65 -90 -40 
TYR 20 C SER 21 N SER 21 CA SER 21 C -65 -90 -40 
SER 21 C LYS 22 N LYS 22 CA LYS 22 C -65 -90 -40 
LYS 22 C LYS 23 N LYS 23 CA LYS 23 C -65 -90 -40 
LYS 23 C VAL 24 N VAL 24 CA VAL 24 C -65 -90 -40 
VAL 24 C ALA 25 N ALA 25 CA ALA 25 C -65 -90 -40 
ALA 25 C LYS 26 N LYS 26 CA LYS 26 C -65 -90 -40 
LYS 26 C HIS 27 N HIS 27 CA HIS 27 C -65 -90 -40 
HIS 27 C LEU 28 N LEU 28 CA LEU 28 C -65 -90 -40 
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LEU 28 C SER 29 N SER 29 CA SER 29 C -65 -90 -40 
SER 29 C LYS 30 N LYS 30 CA LYS 30 C -120 -160 -80 
LYS 30 C CYS 31 N CYS 31 CA CYS 31 C -120 -160 -80 
CYS 31 C GLU 32 N GLU 32 CA GLU 32 C -65 -90 -40 
GLU 33 C CYS 34 N CYS 34 CA CYS 34 C -65 -90 -40 
CYS 34 C LYS 35 N LYS 35 CA LYS 35 C -65 -90 -40 
LYS 35 C ALA 36 N ALA 36 CA ALA 36 C -65 -90 -40 
ALA 36 C LYS 37 N LYS 37 CA LYS 37 C -65 -90 -40 
LYS 37 C ALA 38 N ALA 38 CA ALA 38 C -65 -90 -40 
GLN 39 C LYS 40 N LYS 40 CA LYS 40 C -65 -90 -40 
LYS 40 C LEU 41 N LEU 41 CA LEU 41 C -65 -90 -40 
LEU 41 C LYS 42 N LYS 42 CA LYS 42 C -65 -90 -40 
LYS 42 C ALA 43 N ALA 43 CA ALA 43 C -65 -90 -40 
ALA 43 C LYS 44 N LYS 44 CA LYS 44 C -65 -90 -40 
LYS 44 C ALA 45 N ALA 45 CA ALA 45 C -65 -90 -40 
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